Next Article in Journal
Emission Enhancement and Intermittency in Polycrystalline Organolead Halide Perovskite Films
Next Article in Special Issue
C19-Norditerpenoid Alkaloids from Aconitum szechenyianum and Their Effects on LPS-Activated NO Production
Previous Article in Journal
σ-Bond Electron Delocalization in Oligosilanes as Function of Substitution Pattern, Chain Length, and Spatial Orientation
Previous Article in Special Issue
Inhibitory Effect of Camptothecin against Rice Bacterial Brown Stripe Pathogen Acidovorax avenae subsp. avenae RS-2
Review

Evaluation of Biosynthetic Pathway and Engineered Biosynthesis of Alkaloids

Department of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan
*
Author to whom correspondence should be addressed.
Academic Editor: Michael Wink
Molecules 2016, 21(8), 1078; https://doi.org/10.3390/molecules21081078
Received: 20 July 2016 / Revised: 15 August 2016 / Accepted: 15 August 2016 / Published: 18 August 2016
(This article belongs to the Special Issue Diversity of Alkaloids)
Varieties of alkaloids are known to be produced by various organisms, including bacteria, fungi and plants, as secondary metabolites that exhibit useful bioactivities. However, understanding of how those metabolites are biosynthesized still remains limited, because most of these compounds are isolated from plants and at a trace level of production. In this review, we focus on recent efforts in identifying the genes responsible for the biosynthesis of those nitrogen-containing natural products and elucidating the mechanisms involved in the biosynthetic processes. The alkaloids discussed in this review are ditryptophenaline (dimeric diketopiperazine alkaloid), saframycin (tetrahydroisoquinoline alkaloid), strictosidine (monoterpene indole alkaloid), ergotamine (ergot alkaloid) and opiates (benzylisoquinoline and morphinan alkaloid). This review also discusses the engineered biosynthesis of these compounds, primarily through heterologous reconstitution of target biosynthetic pathways in suitable hosts, such as Escherichia coli, Saccharomyces cerevisiae and Aspergillus nidulans. Those heterologous biosynthetic systems can be used to confirm the functions of the isolated genes, economically scale up the production of the alkaloids for commercial distributions and engineer the biosynthetic pathways to produce valuable analogs of the alkaloids. In particular, extensive involvement of oxidation reactions catalyzed by oxidoreductases, such as cytochrome P450s, during the secondary metabolite biosynthesis is discussed in details. View Full-Text
Keywords: alkaloids; biosynthesis; enzymes; engineered biosynthesis; aromatic amino acids alkaloids; biosynthesis; enzymes; engineered biosynthesis; aromatic amino acids
Show Figures

Graphical abstract

MDPI and ACS Style

Kishimoto, S.; Sato, M.; Tsunematsu, Y.; Watanabe, K. Evaluation of Biosynthetic Pathway and Engineered Biosynthesis of Alkaloids. Molecules 2016, 21, 1078. https://doi.org/10.3390/molecules21081078

AMA Style

Kishimoto S, Sato M, Tsunematsu Y, Watanabe K. Evaluation of Biosynthetic Pathway and Engineered Biosynthesis of Alkaloids. Molecules. 2016; 21(8):1078. https://doi.org/10.3390/molecules21081078

Chicago/Turabian Style

Kishimoto, Shinji, Michio Sato, Yuta Tsunematsu, and Kenji Watanabe. 2016. "Evaluation of Biosynthetic Pathway and Engineered Biosynthesis of Alkaloids" Molecules 21, no. 8: 1078. https://doi.org/10.3390/molecules21081078

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop